Doxorubicin
CAS No. 23214-92-8
Doxorubicin ( —— )
Catalog No. M13659 CAS No. 23214-92-8
Doxorubicin is an Anthracycline Topoisomerase Inhibitor.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDoxorubicin
-
NoteResearch use only, not for human use.
-
Brief DescriptionDoxorubicin is an Anthracycline Topoisomerase Inhibitor.
-
DescriptionDoxorubicin is an Anthracycline Topoisomerase Inhibitor. The mechanism of action of doxorubicin is as a Topoisomerase Inhibitor. The chemical classification of doxorubicin is Anthracyclines.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetTopoisomerase
-
RecptorTopo II
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number23214-92-8
-
Formula Weight543.52
-
Molecular FormulaC27H29NO11
-
Purity>98%(HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESC[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Preissner S, et al. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43.
molnova catalog
related products
-
Indotecan
Indotecan is an effective inhibitor of topoisomerase 1(Top1).
-
SN-38
LE-SN38 is NeoPharm’s NeoLipid liposomal formulation of SN-38, the active metabolite of irinotecan (Camptosar), a chemotherapeutic pro-drug approved for the treatment of advanced colorectal Y.
-
Heveaflavone
Heveaflavone has anti-proliferation effects, it shows moderate Topoisomerase I inhibitory activity. It also possesses a good antioxidant activity via its DPPH free radical scavenging.